G
REGN icon

GenTrust’s Regeneron Pharmaceuticals REGN Stock Holding History

GenTrust’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$664K Buy
859
+290
+51% +$222K 0.03% 136
2025
Q4 		$439K Buy
+569
New +$386K 0.02% 178
2022
Q3 		– Sell
-500
Closed -$296K – 140
2022
Q2 		$296K Buy
500
+200
+67% +$130K 0.02% 115
2022
Q1 		$210K Sell
300
-200
-40% -$127K 0.02% 137
2021
Q4 		$307K Buy
500
+96
+24% +$59K 0.02% 120
2021
Q3 		$244K Buy
404
+4
+1% +$2.48K 0.02% 131
2021
Q2 		$223K Buy
+400
New +$203K 0.02% 132
2020
Q4 		– Sell
-400
Closed -$224K – 153
2020
Q3 		$224K Sell
400
-10
-2% -$6.06K 0.02% 97
2020
Q2 		$256K Buy
+410
New +$233K 0.03% 86

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

GenTrust's REGN Position: Q1 2026 in Review

GenTrust increased its Regeneron Pharmaceuticals (REGN) stake by 51% in Q1 2026, buying an estimated $222K and bringing the position to 859 shares worth $664K. The position accounts for 0.03% of the portfolio, ranked #136.

GenTrust first reported a position in REGN in Q2 2020 and has held it in 9 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • GenTrust held 859 shares of Regeneron Pharmaceuticals worth $664K as of Q1 2026.
  • GenTrust bought 290 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $222K.
  • Regeneron Pharmaceuticals made up 0.03% of GenTrust's portfolio in Q1 2026, its #136 holding.
  • GenTrust first reported a position in Regeneron Pharmaceuticals in Q2 2020 and has held it in 9 quarters since.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on GenTrust's 13F filing for Q1 2026, filed 27 Apr 2026.